M. Mikulica

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.

O. Alfieri, J. Přeček, C. Giannattasio, 2019, European heart journal.

Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

John M. Hancock, O. Alfieri, J. Přeček, 2022, Infection.

Characteristics, management, and outcome of infective endocarditis in the Czech Republic: prospective data from the ESC EORP EURO-ENDO registry.

J. Přeček, J. Widimský, P. Wohlfahrt, 2021, Bratislavske lekarske listy.

Cohort profile The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.

O. Alfieri, J. Přeček, V. Aboyans, 2019, European heart journal. Quality of care & clinical outcomes.

Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

O. Alfieri, J. Přeček, C. Giannattasio, 2022, Infection.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, Lancet.